The
transcription factor hypoxia-inducible factor-1α (HIF-1α), as a master regulator of adaptive responses to
hypoxia, possesses two transcriptional activation domains [TAD, N-terminal (NTAD), and C-terminal (CTAD)]. Although the roles of HIF-1α NTAD in
kidney diseases have been recognized, the exact effects of HIF-1α CTAD in
kidney diseases are poorly understood. Here, two independent mouse models of
hypoxia-induced kidney injury were established using HIF-1α CTAD knockout (HIF-1α CTAD-/-) mice. Furthermore,
hexokinase 2 (HK2) and mitophagy pathway are modulated using genetic and pharmacological methods, respectively. We demonstrated that HIF-1α CTAD-/- aggravated kidney injury in two independent mouse models of
hypoxia-induced kidney injury, including
ischemia/reperfusion-induced kidney injury and unilateral
ureteral obstruction-induced nephropathy. Mechanistically, we found that HIF-1α CTAD could transcriptionally regulate HK2 and subsequently ameliorate
hypoxia-induced tubule injury. Furthermore, it was found that HK2 deficiency contributed to severe renal injury through mitophagy inhibition, while mitophagy activation using
urolithin A could significantly protect against
hypoxia-induced kidney injury in HIF-1α C-TAD-/- mice. Our findings suggested that the HIF-1α CTAD-HK2 pathway represents a novel mechanism of kidney response to
hypoxia, which provides a promising therapeutic strategy for
hypoxia-induced kidney injury.